Definium Therapeutics, Inc. (DFTX) Operating cash flow 2020–2025
Definium Therapeutics, Inc. (DFTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$131.6MFY2025 · since FY2020: -$23.6M → -$131.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$131.6M | -66.3% |
| FY2024 | -$79.1M | -22.9% |
| FY2023 | -$64.4M | -28.4% |
| FY2022 | -$50.1M | -9.4% |
| FY2021 | -$45.8M | -94.2% |
| FY2020 | -$23.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice